Sapheon Secures $19,800,000 Series B Funding Round
Feed Type
Link http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=301c61ce-3d82-4573-b21a-79b2a48c1e2d
Date 9/9/2013
Company Name Sapheon
Mailing Address 951 Aviation Parkway Morrisville, NC 27560 USA
Company Description Sapheon Inc. is a medical device company whose mission is to develop new approaches and disruptive technologies for the treatment of vascular disease.
Proceeds Purposes The funding will support Sapheon’s U.S. pivotal study through final submission to the FDA of the PMA application for the VenaSeal Sapheon